Oppenheimer Remains Sidelined on UiPath Inc. (PATH), 'FY2024 ARR guidance implies that this reported metric will continue declining and remains a stock overhang'
Tweet Send to a Friend
Oppenheimer analyst Brian Schwartz reiterated a Perform rating and {REMOVEPT} price target on UiPath Inc. (NYSE: PATH).The analyst comments "UiPath’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
